Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer

被引：0
|
作者：
Wei Peng Yong
Apurva A. Desai
Federico Innocenti
Jacqueline Ramirez
Dale Shepard
Ken Kobayashi
Larry House
Gini F. Fleming
Nicholas J. Vogelzang
Richard L. Schilsky
Mark J. Ratain
机构：
[1] University of Chicago,Committee on Clinical Pharmacology and Pharmacogenomics
[2] University of Chicago,Department of Medicine
[3] University of Chicago,Cancer Research Center
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Pharmacokinetic modulation; Etoposide; Ketoconazole; Drug interaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：811 / 819
页数：8
相关论文
共 50 条
  • [1] Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer
    Yong, Wei Peng
    Desai, Apurva A.
    Innocenti, Federico
    Ramirez, Jacqueline
    Shepard, Dale
    Kobayashi, Ken
    House, Larry
    Fleming, Gini F.
    Vogelzang, Nicholas J.
    Schilsky, Richard L.
    Ratain, Mark J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (06) : 811 - 819
  • [2] A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancer
    Apurva A. Desai
    Federico Innocenti
    Linda Janisch
    Mark DeMario
    Dale Shepard
    Jacqueline Ramirez
    Gini F. Fleming
    Mark J. Ratain
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 377 - 384
  • [3] A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancer
    Desai, AA
    Innocenti, F
    Janisch, L
    DeMario, M
    Shepard, D
    Ramirez, J
    Fleming, G
    Ratain, MJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (05) : 377 - 384
  • [4] REDUCED ORAL ETOPOSIDE BIOAVAILABILITY IN PATIENTS WITH ADVANCED CANCER OF THE HEAD AND NECK
    DESOIZE, B
    WOIRIN, V
    LEGROS, M
    CONINX, P
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (05) : 348 - 350
  • [5] Pharmacokinetic aspects of oral etoposide
    Tillmann, B
    Krumpelmann, S
    Wurthwein, G
    Wagner, A
    Schulze-Westhoff, P
    Hempel, G
    Jurgens, H
    Boos, J
    KLINISCHE PADIATRIE, 1998, 210 (04): : 159 - 164
  • [6] Oral etoposide for patients with advanced adenocarcinoma of the pancreas
    Eva Thomas
    Pamela Dumas
    Jaffer A. Ajani
    Investigational New Drugs, 1998, 16 : 333 - 335
  • [7] Oral etoposide for patients with advanced adenocarcinoma of the pancreas
    Thomas, E
    Dumas, P
    Ajani, JA
    INVESTIGATIONAL NEW DRUGS, 1999, 16 (04) : 333 - 335
  • [8] Oral etoposide in patients with hematological malignancies -: A clinical and pharmacokinetic study
    Ösby, E
    Liliemark, E
    Björkholm, M
    Liliemark, J
    MEDICAL ONCOLOGY, 2001, 18 (04) : 269 - 275
  • [9] Oral etoposide in patients with hematological malignancies: A clinical and pharmacokinetic study
    Ösby E.
    Liliemark E.
    Björkholm M.
    Liliemark J.
    Medical Oncology, 2001, 18 (4) : 269 - 275
  • [10] Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer
    Soni, N
    Meropol, NJ
    Pendyala, L
    Noel, D
    Schacter, LP
    Gunton, KE
    Creaven, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 766 - 772
12345